AMDA Flu Outbreak Survey 2021

Survey of Medical Directors

Questions about influenza outbreak management and use of antivirals

Question Title

* 1. Within your facility, an outbreak of influenza is (check any that apply):

Two or more residents exhibiting influenza-like symptoms in a unit

Any cases of laboratory-confirmed influenza with other cases of respiratory illness in a unit

Three or more cases of influenza-like illness occurring within 72 hours in residents

A sudden increase in influenza-like cases

One case of influenza confirmed by any laboratory testing method in the presence of other reported influenza-like illness cases in the facility

Question Title

* 2. What administrative procedures do you put in place when an outbreak is identified (check all that apply)?

Limit access to the building for all visitors

Questionnaire completion by staff and visitors about symptoms on entering the building or before coming to work

Exclude healthcare personnel and visitors who are identified with any illness symptoms until their illness has resolved

Place ill residents on droplet precautions with room restriction and exclude from participating in group activities until no longer ill

Implement other outbreak control measures

Question Title

* 3. What antiviral medications do you typically use to treat individual residents when you have an outbreak (check all that apply)?

Amantadine

Baloxavir

Inhaled zanamivir

Intravenous peramivir

Oseltamivir

Rimantadine

Question Title

* 4. What antiviral medications would you consider appropriate to use for prophylaxis of individual residents against influenza when you have an outbreak (check all that apply)?

Amantadine

Baloxavir

Inhaled zanamivir

Oseltamivir

Rimantadine

Question Title

* 5. There are three neuraminidase inhibitors approved for both treatment and prophylaxis of influenza (baloxavir, oseltamivir, and inhaled zanamivir). Do you consider them to be equally acceptable options for your nursing home residents for outbreak control?

Yes

Question Title

* 6. If you responded “No” to question 5, please indicate why?

Cost

Not equally studied

Other (please specify)

Question Title

* 7. Would you, or facilities you work in, consider participating in a clinical trial where facilities were randomized to receive either baloxavir (at least one dose) or oseltamivir (at least two weeks of renally adjusted prophylaxis) as standard of care, to be administered according to the package insert, at no cost for management of influenza outbreaks for the 2021-2022 influenza season?

AMDA Flu Outbreak Survey 2021

Question Title

* 1. Within your facility, an outbreak of influenza is (check any that apply):

Question Title

* 2. What administrative procedures do you put in place when an outbreak is identified (check all that apply)?

Question Title

* 3. What antiviral medications do you typically use to treat individual residents when you have an outbreak (check all that apply)?

Question Title

* 4. What antiviral medications would you consider appropriate to use for prophylaxis of individual residents against influenza when you have an outbreak (check all that apply)?

Question Title

* 5. There are three neuraminidase inhibitors approved for both treatment and prophylaxis of influenza (baloxavir, oseltamivir, and inhaled zanamivir). Do you consider them to be equally acceptable options for your nursing home residents for outbreak control?

Question Title

* 6. If you responded “No” to question 5, please indicate why?

Question Title

Question Title

* 8. Additional comments related to flu outbreaks and antivirals?

Question Title

* 9. Please confirm you are a nursing home medical director.